Abstract
The ability of integrins on the cell surface to mediate cell adhesion to the extracellular matrix ligands is regulated by intracellular signaling cascades. During this signaling process, the talin (TLN) recruited to integrin cytoplasmic tails plays the critical role of the major adaptor protein to trigger integrin activation. Thus, intracellular levels of TLN are thought to determine integrin-mediated cellular functions. However, the epigenetic regulation of TLN expression and consequent modulation of integrin activation remain to be elucidated. Bioinformatics analysis led us to consider miR-200c-3p as a TLN1-targeting miRNA. To test this, we have generated miR-200c-3p-overexpressing and miR-200c-3p-underexpressing cell lines, including HEK293T, HCT116, and LNCaP cells. Overexpression of miR-200c-3p resulted in a remarkable decrease in the expression of TLN1, which was associated with the suppression of integrin-mediated cell adhesion to fibronectin. In contrast, the reduction in endogenous miR-200c-3p levels led to increased expression of TLN1 and enhanced cell adhesion to fibronectin and focal adhesion plaques formation. Moreover, miR-200c-3p was found to target TLN1 by binding to its 3′-untranslated region (UTR). Taken together, our data indicate that miR-200c-3p contributes to the regulation of integrin activation and cell adhesion via the targeting of TLN1.
Similar content being viewed by others
Introduction
Integrins are the family of cell adhesion molecules that mediate cell adhesion in a wide-range of biological contexts1. The adhesiveness of integrins is dynamically regulated by inside-out signals, in which binding of talin to the integrin cytoplasmic domain triggers activation-dependent conformational changes2,3. Talin is a large intracellular protein (~ 270 kDa) critical to the regulation of cell-to-cell and cell-to-extracellular matrix (ECM) communications4. Composed of more than 2500 amino acid residues, and organized into multiple domains5, talin provides multiple binding sites for proteins involved in cell adhesion6. The N-terminal end of talin, also called the head, includes 4 domains (4.1, ezrin, radixin, and moesin; collectively called FERM) and is joined to the C-terminal rod by a linker7. The rod contains 13 α helix-rich domains capped at the end by a dimerization domain. This terminal domain ensures that talin can function as a dimer under physiological conditions8. In mammalian tissues, there are two talin paralogues, TLN1 and TLN2. Both genes (TLN1 and TLN2) encode proteins that share gross identity in amino acid sequences (~ 74%) and domain structures5. In addition, TLN1 and TLN2 largely associate with proteins related to each other, and thus can share many cellular functions9,10. Nonetheless, TLN1 is predominantly expressed in most tissues and appears to be indispensable, as the deletion of this gene in mouse endothelial cells results in internal vascular haemorrhaging and subsequently death11.
Talin, for the most part, coordinates the assembly of multiprotein adhesion complexes that mediate biological processes such as cell migration and, ultimately, more complex phenomena including embryogenesis and tumorigenesis6. To facilitate these assemblages, talin initially forms a nascent complex through its intracellular interaction with the transmembrane receptor, integrin12, and the cytoskeletal protein, actin13. These interactions typically enhance the affinity of integrins to associated ligands, while also establishing a communication linkage between cells and ECM3. Intriguingly, these interactions may induce the unfolding of the talin rod domains, thereby providing more binding sites for other proteins such as vinculin14. Vinculin stabilizes the focal adhesion complex and is crucial to its maturation14. The importance of talin in orchestrating these multiprotein assemblages and impacting several important biological processes has been highlighted in studies with mice whose TLN genes were ablated9,11. Deletion of both TLN1 and TLN2 in cardiomyocytes has resulted in heart failure and consequently death, possibly due to the decrease in expression and function of costameric proteins, notably integrin β1D9.
MicroRNAs (miRNA or miR) are relatively short and single-stranded non-coding RNAs that post-transcriptionally regulate gene expression15. These molecules essentially act as guide RNAs within gene silencing complexes to induce mRNA cleavage and/or translational repression16. Seed sequences, which are miRNA-specific sequences spanning nucleotide positions two to eight, bind response elements within the 3′-UTR of messenger RNAs to heavily facilitate this process17,18. Therefore, miRNAs with similar seed sequences, and likely to have the same gene targets, have been grouped together into miRNA families17,18. miR-200c is a member of the miR-200 family, which also includes miR-141, miR-200a, miR-200b and miR-42919. These members share identical seed sequences with only a single nucleotide difference between subgroups. Notably, this family regulates several important biological processes, most notably epithelial-to-mesenchymal transition (EMT), which is a critical process in cancer metastasis19,20. Expression of these miRNAs is usually upregulated in cancerous epithelial cells and these miRNAs are known to target various transcriptional repressors of E-cadherin, especially the zinc finger E-box binding homeobox 1 (ZEB1) family of transcriptional factors19,20,21, as well as other related proteins to modulate EMT22.
Given the fundamental importance of integrin-mediated cell adhesion to EMT23,24,25, we have performed a bioinformatics analysis using miRDB (www.mirdb.org) and TargetScan (http://www.targetscan.org/vert_72/) in order to identify targets of miR-200 that might regulate integrin-activation. Our analyses identified several miR-200 family members, including miR-200b-3p, miR-200c-3p, and miR-429 that were predicted to target talin genes. Of those miR-200 family members, the role of miR-200c-3p in regulating cellular adhesion or migration has been most extensively studied26,27,28,29,30,31. Thus, we strategically chose to focus on miR-200c-3p and asked whether TLN1 was epigenetically modified by this microRNA. In addition, we sought to determine whether by regulating the expression of TLN1, miR-200c-3p could also impact integrin-mediated cell adhesion. Here we have shown that overexpression of miR-200c-3p decreased the expression of TLN1 and subsequently downregulated integrin-mediated cell adhesion, whereas knockdown of miR-200c-3p increased TLN1 expression and upregulated the integrin-mediated binding to fibronectin. Our study suggests that cellular levels of miR-200c-3p govern integrin-mediated cell adhesion via targeting TLN1.
Results
TLN1 expression is altered significantly by the manipulations of miR-200c-3p levels
To test the hypothesis that miR-200c-3p is involved in the epigenetic regulation of integrin activation triggered by talin, we transduced HEK293T cells with either miR-200c-3p-knockdown vector pmiRZip (miR-200c-3p pmiRZip) to downregulate miR-200c-3p expression, or with pre-miR-200c-3p (miR-200c-3p mimic) to upregulate miR-200c-3p expression. The miR-200c-3p pmiRZip transduced clones exhibited an approximately 25% decrease in miR-200c-3p expression (Fig. 1A). The clones transduced with miR-200c-3p mimic exhibited greater than 100 times increase in miR-200c-3p levels (Fig. 1D). As ZEB1 was previously shown to be a target of miR-200c-3p20,21,32,33, we next examined the expression levels of ZEB1 in different clones. As expected, we confirmed that ZEB1 expression was increased in the miR-200c-3p pmiRZip-transduced cells, whereas ZEB1 expression was suppressed in the miR-200c-3p mimic-transduced cells (Fig. 1B,E). Then, we proceeded to investigate how TLN1 expression was affected by miR-200c-3p levels. The miR-200c-3p pmiRZip transduced clones exhibited a marked increase in TLN1 expression, while the miR-200c-3p mimic-transduced cells showed a significant reduction in TLN1 expression (Fig. 1C,F). In addition, miR-200c-3p mimic and miR-200c-3p pmiRZip transduced clones did not show any changes in the expression of interleukin-4 (IL-4) and mucosal address in cell adhesion molecule-1 (MAdCAM-1), both of which are not predicted as miR-200c-3p targets and, thereby, used as negative controls (Fig. S2A–D).
In addition to TLN1, the bioinformatics analysis using TargetScan predicted that TLN2 was among the miR-200c-3p’s targets. Other focal-adhesion proteins such as vinculin, paxillin, integrin-linked kinase (ILK) and focal adhesion kinase (FAK) were not predicted as miR-200c-3p’s targets. Endogenous levels of TLN2 were much lower in HEK293T cells than those of TLN1 (Fig. S3A), although the expression of TLN2 was also affected by miR-200c-3p (Fig. S3B,C). Thus, in the present study we decided to focus only on the predominant talin gene, TLN1 .
To substantiate the findings that TLN1 expression is inversely correlated with the levels of miR-200c-3p in HEK293T cells, we expanded our analysis to the cell lines HCT116 (a human colorectal cancer cell line) and LNCaP (a human prostate cancer cell line), which express high levels of miR-200c-3p34,35. HCT116 and LNCaP cells transduced with miR-200c-3p pmiRZip were subjected to the analysis for TLN1 and ZEB1 expression. We confirmed in both miR-200c-3p pmiRZip-transduced HCT116 and LNCaP cells a significant decrease in miR-200c-3p expression (Fig. S4) and concomitant increase in the ZEB1 and TLN1 expression (Fig. S5), compared to control cells. Therefore, miR-200c-3p-mediated downregulation of TLN1 shown in HEK293T cells (Fig. 1) was also substantiated in cells that express relatively higher levels of endogenous miR-200c-3p.
We next performed immunofluorescence analysis to ask whether miR-200c-3p also triggers a reduction in TLN1 expression in HEK293T cells. The cells were stained with anti-TLN1 antibody and an allophycocyanin-tagged secondary antibody and analyzed for levels of TLN1 protein. As shown in the representative images in Fig. 2, the cells transduced with miR-200c mimic vector exhibited a drastic reduction in TLN1 expression (Fig. 2B), compared to those transduced with control vector (Fig. 2A). In contrast, the cells transduced with miR-200c-3p pmiRZip vector showed a remarkable increase in TLN1 (Fig. 2C). As a control to gauge a background signal level, the miR-200c-3p pmiRZip-transduced cells stained with isotype control (mouse IgG1) hardly showed signals (Fig. 2D). A quantitative analysis of multiple images confirmed that talin-1 protein significantly increased in the miR-200c-3p pmiRZip-transduced cells and decreased in miR-200c-3p mimic-transduced cells (Fig. 2E), which was further supported by the immunoblot analysis (Fig. 2F). Taken together, miR-200c-3p-mediated downregulation of TLN1 expression as shown at both mRNA and protein levels, thereby suggesting that miR-200c-3p regulates TLN1 expressions.
miR-200c-3p targets the 3′-UTR of TLN1
To study the epigenetic mechanism by which miR-200c-3p regulates TLN1 expression, we investigated the interactions of miR-200c-3p with 3′-UTR of TLN1 mRNA. An in silico analysis predicted that there are two miR-200c-3p binding sites within 3′-UTR of TLN1 (www.mirdb.org) (Fig. 3A). To demonstrate that miR-200c-3p binds 3′-UTR of the TLN1, thereby regulating its expression, a dual-luciferase reporter assay system was employed. We co-transfected HEK293T cells with either miRNA-200c-3p pmiRZip construct or mimic/pre-miR construct and a 3′-UTR (TLN1) firefly luciferase construct that contained the two miR-200c-3p binding sites, designated as miR-200c-3p pmiRZip and mimic, respectively. Control cells were co-transfected with the empty lentivector and the same firefly luciferase construct as mentioned above, termed control vector. Three of all transfectants (control vector, miR-200c-3p pmiRZip, and miR-200c-3p mimic) were further transfected with Renilla luciferase reporter vector to normalize the firefly luciferase activity. Using this dual-reporter assay system, we measured luciferase reporter activities. Compared to those in control-vector transfected cells, the TLN1 3′-UTR-specific firefly luciferase activities were significantly increased in the miR-200c-3p pmiRZip-transfected cells, and inversely, decreased in the miR-200c-3p mimic-transfected cells (Fig. 3B). Collectively, these results support a possible mechanism that miR-200c-3p regulates TLN1 expression by directly targeting its 3′-UTR.
miR-200c-3p suppresses cellular binding to fibronectin possibly by reducing TLN1
TLN is known to be the major adaptor protein that is indispensable for the final common step in integrin-mediated cellular adhesion3,6,36. We hypothesized that intracellular levels of miR-200c-3p determine integrin-mediated cell adhesion by modulating TLN1 expression. To test this, we conducted a cell-adhesion assay using miR-200c-3p pmiRZip and mimic clones. After coating V-bottom 96-well plates with fibronectin, a major ECM integrin ligand for integrin α5β137, we measured the strength of cell adhesion in the presence of 1 mM CaCl2 and 1 mM MgCl2. The miR-200c-3p pmiRZip-transduced cells exhibited a remarkable increase in binding to fibronectin, while a clone of miR-200c-3p mimic-transduced cells displayed significantly lower fibronectin adhesion, compared to cells transduced using vector control (Fig. 4A). Furthermore, we have shown that both HCT116 and LNCaP cells transduced with miR-200c-3p pmiRZip also exhibited a significant increase in binding to fibronectin (Fig. S6), confirming the results from analysis with HEK293T cells (Fig. 4A). To substantiate the results obtained with the V-bottom plate cell adhesion assay, in which unbound cells were removed by the centrifugal force, we performed a conventional adhesion assay using a flat-bottom plate, which unbound cells were removed by the washing procedure that generated turbulent flow. The conventional cell adhesion assay recapitulated the results in HEK293T cells (Fig. S7A) and, thereby, showed that integrin α5β1 mediated cell adhesion to fibronectin (Fig. S7B).
Direct association of vinculin with talin and actin triggers the formation of focal adhesion via integrin clustering, which governs cell adhesion and migration38. As talin is the essential component of focal adhesion39, we have studied how miR-200c-3p affected the formation of focal adhesion plaques. To this end, we performed immunofluorescence imaging of vinculin and actin in the miR-200c-3p pmiRZip-transduced HEK293T cells. Compared with control vector-transduced cells (Fig. S8A), miR-200c-3p pmiRZip-transduced cells exhibited a remarkable increase in the zones of association of vinculin with actin (Fig. S8B). Thus, these results suggest that downregulation of miR-200c-3p promotes the formation of focal adhesion plaques.
miR-200c-3p-mediated modulation of TLN1 levels is thought to affect cell adhesion to fibronectin by impacting on the activation-dependent conformational changes of integrin α5β12,3. We thus sought to examine how miR-200c-3p loss-of-function (knockdown) and gain-of-function/overexpression (mimic) would affect integrin conformations probed by an activation-dependent epitope. To examine whether miR-200c-3p expression altered integrin’s activation we employed antibody HUTS-4, which preferentially binds to an integrin epitope that is exposed only when β1 integrin is in an active state40 in combination with flow cytometry. As shown in Fig. 4B,C, miR-200c-3p pmiRZip- and miR-200c-3p mimic-transduced cells exhibited a significant increase and reduction, respectively, in binding of HUTS-4, compared with control vector-transduced cells. Overall, these data underscore that miR-200c-3p modifies talin-1-mediated integrin activation pathways that culminate to the epigenetic regulation of integrin-mediated cell adhesion.
Discussion
A proper balance in the activation and deactivation of integrins is critical for up- and down-regulating cell adhesion to ECM, which constitute some of the basic steps for various biological and pathological processes41,42. Integrin activation is achieved by inside-out and intracellular signaling that culminates in the association of multiple adaptor proteins to integrin cytoplasmic tails. TLN, composed of TLN1 and TLN2, is a main adaptor molecule essential to a final common step in integrin activation. Accordingly, it is of great importance to understand the molecular mechanisms by which the expression and function of TLN is regulated by endogenous molecules such as miRNAs. Here we have demonstrated that miR-200c-3p plays the important role in the epigenetic regulation of TLN1, thereby potentially participating in the fine-tuning of the integrin activation and conformational regulation.
miR-200c-3p, which belongs to the miR-200 family, is known to be a functionally versatile miRNA that negatively regulates EMT by targeting ZEB120,22,43, which was also confirmed in our study (Fig. 1B,E). This miRNA has also been shown to modulate cancer stem-cell heterogeneity by targeting home domain-interacting protein kinase 1 (HIPK1)30. In addition, miR-200c-3p suppresses tumor-cell growth and invasion by targeting B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) and E2F transcription factor 3 (E2F3)29, both of which have similarly been targets of miR-128-144 and miR-429 (a member of the miR-200 family)45. Thus, miR-200c-3p is thought to comprise the miRNA-target gene regulatory network that interferes with epithelial-carcinoma invasiveness. Hoefert et al. have demonstrated that miR-200 family members, including miR-200c-3p, regulate epithelial cell binding and growth during normal hair morphogenesis by cooperatively targeting multiple genes such as cyclin G2 (CCNG2), cyclin D2 (CCND2), cofilin-2 (CFL2), and snail family transcriptional repressor 2 (SNAI2)46. In addition, miR-200c-3p has been also shown to downregulate NADPH oxidase activator termed Noxa which is known to mediate apoptosis47, to thereby contribute to attenuating pro-apoptotic pathway of non-malignant cells48. Zhang et al., have reported that by targeting Notch1, miR-200c suppressed endothelial proliferation and metabolism under hyperglycaemic state49.
Kindlin-2 is structurally and functionally related to the TLN50, and transcripts of kindlin-2 have proven to be a direct target of miR-200b for the modulation of EMT in breast cancer cell metastases51. As mentioned earlier, bioinformatics analysis has shown that miR-200 family members can potentially modulate TLN1 expression. Despite scant evidence for any direct interaction between these miR-200 members and TLN1 thus far, some other miRNAs such as miR-9, miR-124, and miR-330 have been previously reported to target TLN1 in order to regulate its expression in cancer cell. Several miRNAs such as miR-9, miR-124, and miR-330 have been previously reported to target TLN1 to regulate its expression. Treatment with miR-9 for ovarian serous carcinoma cells suppressed their migratory and invasive capabilities by targeting TLN1 and downregulating its expression52. Likewise, miR-124 was effective at targeting TLN1 and interfering with dynamic activity of prostate cancer cells53. In addition, miR-330 has been shown to regulate the proliferative and angiogenic properties of hepatocellular carcinoma cells by targeting TLN154. However, miRNA regulation of TLN1 expression, which leads to the modification of integrin-mediated cell adhesion, remains to be elucidated. Thus, in this study we sought to identify a new TLN1-targeting miRNA and examine the effects of its altered levels on cell adhesiveness.
miRNAs and their targets participate to regulatory network implicated in cellular functions such as invasion through a coordinated role played by multiple components55. It is unlikely that single-gene downregulation by certain miRNA independently impinge on modifying cell adhesion. Indeed, miR-200c-3p may have several-hundred targets56. Therefore, a possibility cannot be ruled out that the reduced cell adhesion occurred by miR-200c-3p-mediated TLN1 downregulation is integrated with the concomitant expressional decrease in other targets such as kindlin-257 or E2F transcription factor 3 (E2F3)29.
Our current results support the possibility that miR-200c-3p directly targets TLN1 and regulates its expression. There is currently no evidence supporting or refuting the possibility that TLN1 is transcriptionally regulated by ZEB1, an EMT transcription factor targeted by miR-200c-3p. However, given the complexity and interdependence of the miRNA regulatory network58, further investigations in the future may reveal any secondary effects of miR-200c-3p regulatory network that could impact on regulating TLN1 expression.
With regards to current finding that miR-200c-3p targets TLN1 (Fig. 3B), miR-200c-3p-dependent TLN1 up- and down-regulation modified integrin-induced cell adhesion to fibronectin (Fig. 4A). These results support the notes that upregulation of TLN1 itself plays roles in activating integrins as a final trigger3,36,59. Notably, the TLN1 upregulated by a reduction in the intracellular miR-200c-3p was capable of converting integrin’s conformation to the high-affinity state. Based on the experiments using HUTS-4 specific for the active β1 integrin conformation40, the reduction of miR-200c-3p in the pmiRZip-transduced cells has enhanced the levels of β1-integrin activation, compared to control cells; and vice versa in case of the miR-200c-3p mimic-transduced cells (Fig. S7). Thus, TLN1-mediated regulations of integrin conformation and function may rely, at least partly, on cellular levels of miR-200c-3p. In agreement with these notes, it is intriguing to corroborate further roles played by miR-200c-3p in regulating β1 integrin-driven outside-in signaling in near future.
In conclusion, we have demonstrated that miR-200c-3p targets TLN1. In accordance with this finding, overexpression of miR-200c-3p led to reduced cell adhesiveness, via TLN1 downregulation, to fibronectin, which is an abundant ECM ligand for integrins such as α5β1 and αV classes37,60. Moreover, abrogation of this miRNA resulted in increased cell binding and the formation of focal adhesion plaques. Figure 5 illustrates this proposed model, in which an miR-200c-3p-mediated change in TLN1 levels regulated integrin activation and subsequent cell adhesion to fibronectin. Based on our current findings, it would be worthwhile to further examine the effects of TLN1 targeting by miR-200c-3p on the functionality of different integrins (e.g., αLβ2, α4β1, or α4β7) that adhere to their cognate ligands (e.g., intercellular adhesion molecule 1, ICAM-1; vascular cell adhesion molecule 1, VCAM-1; or mucosal address in cell adhesion molecule 1, MAdCAM-1, respectively) in different cell types including immune cells.
Methods
Cell culture
HEK293T, HEK293TN, HCT116, and LNCaP cell lines were obtained from American Type Culture Collection (ATCC) (Manassas, VA, USA) and System Biosciences (Palo Alto, CA, USA), respectively, and were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Nacalai, Kyoto, Japan) supplemented with 4 mM l-glutamine (Nacalai), 10% fetal bovine serum (FBS) (Equitech-Bio, Kerrville, TX, USA) and penicillin/streptomycin (Nacalai) according to the manufacturer’s instructions.
Generation of cells stably expressing miR-200c-3p mimic/pre-miR and antagomir
The lentivectors pMIRNA1 and pmiRZip (System Biosciences) containing miR-200c mimics and antagomirs, respectively, as well as control empty lentivectors (System Biosciences) were used to generate the HEK293T cell transductants for each gene. In brief, we first transduced HEK293TN cells with the aforementioned lentivectors by using PureFection reagent (System Biosciences) to package the viral particles, according to the manufacturer’s instructions. HEK293T, HCT116, and LNCaP cells were seeded at 3 × 105 cells/ml in 6-well plates and allowed to grow until approximately 60% confluency. The cells were then transduced with lentiviral particles for either miRNA-200c-3p mimics or pmiRZip. Control cells were transduced with empty lentiviral particles. To enhance the transduction efficiency, polybrene (Nacalai) was added to culture medium at a concentration of 8 µg/ml. After 24 h, the culture medium was replaced with fresh medium containing 1 µg/ml puromycin (InvivoGen, San Diego, CA, USA). Cells were further cultured for 48 h to select those cells resistant to puromycin. Single-cell clones of HEK293T were generated using the the method of limiting dilution. Briefly, the cells (5 per ml) were seeded in 96-well plates and cultured in the presence of 1 µg/ml puromycin for 7–14 days. Wells with single-cell colonies were isolated and expanded further for subsequent experiments.
Reverse transcription and quantitative polymerase chain reaction (RT-qPCR)
Total RNA was extracted from cells using Trizol reagent (Thermo Fisher Scientific, Waltham, MA, USA) and measured for the concentration using a NanoDrop2000 spectrophotometer (Thermo Fisher Scientific). Approximately 1 µg of RNA was used to perform RT in a reaction by using a Prime Script RT Kit (Takara Bio, Shiga, Japan) for mRNA or a Mir-X miRNA First-Strand Synthesis Kit (Takara Bio) for miRNA according to the manufacturer’s instructions. Then, qPCR was conducted by using a PowerUp SYBR Master Mix (Applied Biosystems, Forster City, CA, USA) and a StepOne Real-Time PCR device (Applied Biosystems). U6 and β-actin were used as reference genes to analyze the relative expressions of miRNA and mRNAs, respectively. For the miR-200c-3p, a universal primer (Thermo Fisher Scientific) was used as a reverse primer. Primer sequences (5′ → 3′) used in the qPCR were as follows: U6, GCGCGTCGTGAAGCGTTC (forward) and GTGCAGGGTCCGAGGT (reverse); hsa-miR-200c-3p, TAATACTGCCGGGTAATGATGGA; β-actin, GATGCAGAAAGGAGATCACTG (forward) and CGATCCACACGGAGTACTTG (reverse); TLN1, TCTCCCAAAATGCCAAGAAC (forward) and TGGCTATTGGGGTCAGAGAC (reverse); ZEB1, GCCAATAAGCAAACGATTCTG (forward) and TTTGGCTGGATCACTTTCAAG (reverse); IL-4, ACTTTGAACAGCCTCACAGAG (forward) and TTGGAGGCAGCAAAGATGTC (reverse); and MAdCAM-1, CTGTACGGCCCACAAAGTCA (forward) and TCTGTCACCCTGAACAGCAC (reverse). Relative expression to the reference gene using comparative threshold (CT) values was normalized to controls and shown as 2−∆∆CT unless otherwise specified.
Immunofluorescence analysis
The 10 µg/ml fibronectin (Sigma-Aldrich, St. Louis, MO, USA) was coated onto 18-mm glass coverslips (Instruments, Hamden, CT, USA) for 1 h at 37 °C61. HEK293T cell clones in the culture medium (see Sect. 2.1. above) were cultured on the coverslips for 16 h and then fixed with ice-cold methanol for 1 min as described previously62. Cells were then blocked in 1% bovine serum albumin (BSA) (Sigma-Aldrich) for 1 h at 37 °C and incubated with 7 µg/ml of mouse anti-human TLN1 monoclonal antibody (mAb) (97H6, Bio-Rad, Hercules, CA, USA) or mouse IgG1 (isotype) (Biolegend) for 16 h at 4 °C. Then, the cells were incubated with allophycocyanin-labeled anti-mouse IgG antibody (Biolegend, San Diego, CA, USA) at room temperature for 30 min and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) for nuclear staining. In some experiments, the cells were stained for vinculin and phalloidin (actin) by using actin cytoskeleton/focal adhesion staining kit (Merck, Darmstadt, Germany) according to the manufacturer’s instructions. The coverslips were mounted on slide glasses using an Aqueous Mounting Medium (Abcam, Cambridge, UK). Images were acquired on a fluorescence microscope (BZ-X710, Keyence, Osaka, Japan).
To quantify the expression of TLN1, images were analyzed using ImageJ (v1.53f) (NIH, Bethesda, MD, USA) as previously described63. In brief, regions of interest were outlined using a drawing tool and mean fluorescence was measured. Adjacent background readings were also performed. Corrected total cellular fluorescence (CTCF) was calculated by a formula of {integrated density – (area of selected cell × mean fluorescence of background readings)}. Several images per each group were used to acquire CTCF which was shown as mean values of the relative fluorescence (arbitrary units). Bar graphs and statistical analysis {one-way analysis of variance (ANOVA)} were done using Prism 8 (GraphPad, San Diego, CA, USA).
Immunoblot analysis
Immunoblot analysis was done as previously described with some modifications64. In brief, cells were lysed in RIPA buffer (Nacalai), and proteins were loaded at 30 µg per each well of 7.5% precast protein gels (Bio-Rad) and then separated by the sodium dodecyl sulfate polyacrylamide gel electrophoresis. The protein-separated gels were transferred electrically to PVDF membranes (Cosmo Bio, Tokyo, Japan). After the membranes were blocked with 5% skim milk and incubated with primary antibody to TLN1 (Bio-Rad) or β-actin (Sigma) followed by horseradish peroxidase-conjugated anti-mouse IgG secondary antibody (Abcam), the bands were visualized via chemiluminescence using ECL substrate kit (Merck) and ImageQuant LAS 4000 mini (Cytiva, Tokyo, Japan).
Dual-luciferase reporter assay
HEK293T cells were seeded in a 96-well plate and allowed to grow to approximately 80% confluency. The cells were co-transfected with a pMirTarget-TLN1-3′ UTR vector (containing a firefly luciferase gene) (OriGene, Rockville, MD, USA), a pRL-SV40 vector (containing a Renilla luciferase gene) (Promega, Madison, WI, USA), and a pMIRNA1-miR-200c-3p mimic vector or pmiRZip antagomir vector by using Lipofectamine 2000 (Thermo Fisher Scientific). For control, cells were co-transfected with pMirTarget-TLN1-3′ UTR vector, pRL-SV40 vector, and a pSIH-H1 vector (System Biosciences). After 48 h of incubation, firefly and Renilla luciferase reporter activity were measured with a luminometer (2030 ARVO X4 multi label reader) using a Dual-Glo Luciferase Assay System (Promega) according to the manufacturer’s instructions. After normalizing reporter activities of firefly luciferase to those of Renilla luciferase, the ratio of luciferase activities was obtained.
V-bottom well adhesion assay
Cells were fluorescently labeled with 1 mM 3′-O-acetyl-2′,7′-bis(carboxyethyl)-4 or 5-carboxyfluorescein, diacetoxymethyl ester (BCECF-AM) (Dojindo, Kumamoto, Japan). The cells were then washed with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-buffered saline (HBS) and counted. The wells of V-bottom 96-well plates (Greiner Bio-One GmbH, Frickenhausen, Germany) were coated with 10 µg/ml of fibronectin (Sigma-Aldrich) and incubated at room temperature for 90 min. The wells were then blocked with 2% BSA (Sigma-Aldrich) in HBS at 37 °C for 60 min and then washed twice with phosphate-buffered saline (PBS). Equal numbers of miR-200c-3p pmiRZip- or mimic/pre-miR-transduced cells or control vector-transduced cells resuspended in HBS were added to the well (2 × 105/ml) with either 2 mM ethylenediaminetetraacetic acid (EDTA) (Wako) or 1 mM CaCl2 (Sigma-Aldrich) plus 1 mM MgCl2 (Sigma-Aldrich) and incubated at room temperature for 30 min. The samples treated with EDTA were used for estimating background adhesion to normalize integrin-mediated adhesion in the presence of Ca2+ and Mg2+65. The plates were centrifuged at 1500 rpm for 5 min to generate a shear stress and separate bound cells from unbound cells. Thus, this method can be suitable to calculate integrin-mediated cell adhesion, because the integrins usually undergo their conformational activation on cells in response to shear stress. After measurement of the fluorescence signal of the unbound cells by using a 2030 ARVO plate reader (PerkinElmer, Waltham, MA, USA), the cell adhesion to fibronectin was quantified as previously described66. Considering the post-centrifugal value of fluorescence in this assay was inversely proportional to percentage of the cells bound to fibronectin, the percentage of the bound cells was calculated by using the formula {100 – fluorescence (Ca2+/Mg2+) ÷ fluorescence (EDTA) × 100} as described previously with minor modifications2,67.
Flat-bottom well adhesion assay
The adhesion assay using flat-bottom wells was performed to examine post-ligand binding as previously described68,69 with some modifications. The 96-well flat-bottom well plates (Thermo Fisher Scientific) were coated with fibronectin at 10 µg/ml and blocked with 2% BSA, followed by washes with PBS three times. As described above, the cells were fluorescently labeled with BCECF-AM. The cells were then incubated with either blocking antibody (5 µg/ml) to integrin β1 (Biolegend) and α5 (Biolegend) or mouse IgG1 (5 µg/ml, isotype control) (Biolegend) in the presence of Ca2+ (1 mM) and Mg2+ (1 mM) at room temperature for 30 min. After cells were added to the wells at 2 × 105/ml, the plates were incubated at 37 °C for 60 min and washed three times gently with prewarmed PBS. The percentage of bound cells was calculated by measuring fluorescence with the 2030 ARVO plate reader before and after removal of unbound cells as described previously69.
Flow cytometry
Antibody to activation-dependent epitope of β1 integrin (HUTS-4) was obtained from Sigma. Isotype control (mouse IgG2b) was purchased from Biolegend. The cells treated with HUTS-4 or isotype were fluorescently labeled by allophycocyanin-labeled anti-mouse IgG antibody, washed with PBS containing 2% FBS and 2 mM EDTA, and analyzed using BD Accuri C6 flow cytometer and software (BD Biosciences).
Statistical analysis
Data are expressed as the mean ± standard errors of the mean (SEM). The two-tailed and unpaired Student’s t-test were used to compare two groups and one-way ANOVA was for more than two groups. P < 0.05 was considered significant. All assays were performed in more than triplicates and experiments were repeated at least three times. Statistical analysis was done with Prism 8 (GraphPad).
References
Shimaoka, M., Takagi, J. & Springer, T. A. Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct. 31, 485–516 (2002).
Kim, M., Carman, C. V. & Springer, T. A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301, 1720–1725 (2003).
Tadokoro, S. et al. Talin binding to integrin b tails: A final common step in integrin activation. Science 302, 103–106 (2003).
Gough, R. E. & Goult, B. T. The tale of two talins: Two isoforms to fine-tune integrin signalling. FEBS Lett. 592, 2108–2125. https://doi.org/10.1002/1873-3468.13081 (2018).
Monkley, S. J., Pritchard, C. A. & Critchley, D. R. Analysis of the mammalian talin2 gene TLN2. Biochem. Biophys. Res. Commun. 286, 880–885. https://doi.org/10.1006/bbrc.2001.5497 (2001).
Klapholz, B. & Brown, N. H. Talin: The master of integrin adhesions. J. Cell Sci. 130, 2435–2446. https://doi.org/10.1242/jcs.190991 (2017).
Elliott, P. R. et al. The structure of the talin head reveals a novel extended conformation of the FERM domain. Structure 18, 1289–1299. https://doi.org/10.1016/j.str.2010.07.011 (2010).
Gingras, A. R. et al. The structure of the C-terminal actin-binding domain of talin. EMBO J. 27, 458–469. https://doi.org/10.1038/sj.emboj.7601965 (2008).
Manso, A. M. et al. Loss of mouse cardiomyocyte talin-1 and talin-2 leads to beta-1 integrin reduction, costameric instability, and dilated cardiomyopathy. Proc. Natl. Acad. Sci. USA 114, E6250–E6259. https://doi.org/10.1073/pnas.1701416114 (2017).
Zhang, X. et al. Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nat. Cell Biol. 10, 1062–1068 (2008).
Pulous, F. E., Grimsley-Myers, C. M., Kansal, S., Kowalczyk, A. P. & Petrich, B. G. Talin-dependent integrin activation regulates VE-cadherin localization and endothelial cell barrier function. Circ. Res. 124, 891–903. https://doi.org/10.1161/CIRCRESAHA.118.314560 (2019).
Anthis, N. J. et al. The structure of an integrin/talin complex reveals the basis of inside-out signal transduction. EMBO J. 28, 3623–3632 (2009).
Muguruma, M., Matsumura, S. & Fukazawa, T. Direct interactions between talin and actin. Biochem. Biophys. Res. Commun. 171, 1217–1223 (1990).
Izard, T. et al. Vinculin activation by talin through helical bundle conversion. Nature 427, 171–175. https://doi.org/10.1038/nature02281 (2004).
Bartel, D. P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
Gregory, R. I., Chendrimada, T. P., Cooch, N. & Shiekhattar, R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123, 631–640. https://doi.org/10.1016/j.cell.2005.10.022 (2005).
Bartel, D. P. Metazoan microRNAs. Cell 173, 20–51. https://doi.org/10.1016/j.cell.2018.03.006 (2018).
Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20. https://doi.org/10.1016/j.cell.2004.12.035 (2005).
Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593–601. https://doi.org/10.1038/ncb1722 (2008).
Burk, U. et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582–589. https://doi.org/10.1038/embor.2008.74 (2008).
Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894–907. https://doi.org/10.1101/gad.1640608 (2008).
Bracken, C. P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 68, 7846–7854. https://doi.org/10.1158/0008-5472.CAN-08-1942 (2008).
Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M. & Moses, H. L. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276, 46707–46713. https://doi.org/10.1074/jbc.M106176200 (2001).
Liu, J. et al. Talin determines the nanoscale architecture of focal adhesions. Proc. Natl. Acad. Sci. USA. 112, E4864-4873. https://doi.org/10.1073/pnas.1512025112 (2015).
Chinthalapudi, K., Rangarajan, E. S. & Izard, T. The interaction of talin with the cell membrane is essential for integrin activation and focal adhesion formation. Proc. Natl. Acad. Sci. USA. 115, 10339–10344. https://doi.org/10.1073/pnas.1806275115 (2018).
Liu, Y. et al. MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2. Sci. Rep. 7, 13598. https://doi.org/10.1038/s41598-017-14088-3 (2017).
Title, A. C. et al. Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion. Nat. Commun. 9, 4671. https://doi.org/10.1038/s41467-018-07130-z (2018).
Zhang, D. D., Li, Y., Xu, Y., Kim, J. & Huang, S. Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth. Oncogene 38, 1106–1120. https://doi.org/10.1038/s41388-018-0499-2 (2019).
Liu, L. et al. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3. J. Transl. Med. 12, 305. https://doi.org/10.1186/s12967-014-0305-z (2014).
Liu, B. et al. miR-200c/141 regulates breast cancer stem cell heterogeneity via targeting HIPK1/beta-catenin axis. Theranostics 8, 5801–5813. https://doi.org/10.7150/thno.29380 (2018).
Aunin, E., Broadley, D., Ahmed, M. I., Mardaryev, A. N. & Botchkareva, N. V. Exploring a role for regulatory miRNAs in wound healing during ageing: Involvement of miR-200c in wound repair. Sci. Rep. 7, 3257. https://doi.org/10.1038/s41598-017-03331-6 (2017).
Howe, E. N., Cochrane, D. R. & Richer, J. K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 13, R45. https://doi.org/10.1186/bcr2867 (2011).
Gao, H. X., Yan, L., Li, C., Zhao, L. M. & Liu, W. miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1. Mol. Med. Rep. 14, 4135–4143. https://doi.org/10.3892/mmr.2016.5770 (2016).
Tsunoda, T. et al. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells. Anticancer Res. 31, 2453–2459 (2011).
Lin, J., Lu, Y., Zhang, X., Mo, Q. & Yu, L. Effect of miR-200c on proliferation, invasion and apoptosis of prostate cancer LNCaP cells. Oncol. Lett. 17, 4299–4304. https://doi.org/10.3892/ol.2019.10102 (2019).
Shattil, S. J., Kim, C. & Ginsberg, M. H. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 11, 288–300. https://doi.org/10.1038/nrm2871 (2010).
Park, E. J. et al. Integrin-ligand interactions in inflammation, cancer, and metabolic disease: Insights into the multifaceted roles of an emerging ligand irisin. Front. Cell Dev. Biol. 8, 588066. https://doi.org/10.3389/fcell.2020.588066 (2020).
Burridge, K. & Mangeat, P. An interaction between vinculin and talin. Nature 308, 744–746. https://doi.org/10.1038/308744a0 (1984).
Boujemaa-Paterski, R. et al. Talin-activated vinculin interacts with branched actin networks to initiate bundles. Elife https://doi.org/10.7554/eLife.53990 (2020).
Luque, A. et al. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355–425) of the common b1 chain. J. Biol. Chem. 271, 11067–11075 (1996).
Park, E. J., Yuki, Y., Kiyono, H. & Shimaoka, M. Structural basis of blocking integrin activation and deactivation for anti-inflammation. J. Biomed. Sci. 22, 51. https://doi.org/10.1186/s12929-015-0159-6 (2015).
Bachmann, M., Kukkurainen, S., Hytonen, V. P. & Wehrle-Haller, B. Cell adhesion by integrins. Physiol. Rev. 99, 1655–1699. https://doi.org/10.1152/physrev.00036.2018 (2019).
Zhou, X. et al. miR-200c inhibits TGF-beta-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer. Cancer Gene Ther. 25, 68–76. https://doi.org/10.1038/s41417-017-0005-y (2018).
Shan, Z. N. et al. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Oncotarget 7, 78813–78826. https://doi.org/10.18632/oncotarget.12385 (2016).
Qiu, M. et al. MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma. Urol. Oncol. 33(332), e318–e339. https://doi.org/10.1016/j.urolonc.2015.03.016 (2015).
Hoefert, J. E., Bjerke, G. A., Wang, D. & Yi, R. The microRNA-200 family coordinately regulates cell adhesion and proliferation in hair morphogenesis. J. Cell Biol. 217, 2185–2204. https://doi.org/10.1083/jcb.201708173 (2018).
Oda, E. et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053–1058 (2000).
Lerner, M., Haneklaus, M., Harada, M. & Grander, D. MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors. PLoS ONE 7, e36490. https://doi.org/10.1371/journal.pone.0036490 (2012).
Zhang, Y., Guan, Q. & Jin, X. miR-200c serves an important role in H5V endothelial cells in high glucose by targeting Notch1. Mol. Med. Rep. 16, 2149–2155. https://doi.org/10.3892/mmr.2017.6792 (2017).
Montanez, E. et al. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev. 22, 1325–1330 (2008).
Sossey-Alaoui, K., Pluskota, E., Szpak, D., Schiemann, W. P. & Plow, E. F. The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200b. Sci. Rep. 8, 7360. https://doi.org/10.1038/s41598-018-25373-0 (2018).
Tang, H. et al. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1. Int. J. Mol. Med. 32, 381–388. https://doi.org/10.3892/ijmm.2013.1400 (2013).
Zhang, W. et al. MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells. Cancer Cell Int. 15, 49. https://doi.org/10.1186/s12935-015-0189-x (2015).
Gao, J., Yin, X., Yu, X., Dai, C. & Zhou, F. Long noncoding RNA LINC00488 functions as a ceRNA to regulate hepatocellular carcinoma cell growth and angiogenesis through miR-330-5. Dig. Liver Dis. 51, 1050–1059. https://doi.org/10.1016/j.dld.2019.03.012 (2019).
Bracken, C. P. et al. Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. EMBO J. 33, 2040–2056. https://doi.org/10.15252/embj.201488641 (2014).
Hurteau, G. J., Spivack, S. D. & Brock, G. J. Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR. Cell Cycle 5, 1951–1956. https://doi.org/10.4161/cc.5.17.3133 (2006).
Yu, Y. et al. Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family. Int. J. Cancer 133, 1368–1379. https://doi.org/10.1002/ijc.28151 (2013).
Obermayer, B. & Levine, E. Exploring the miRNA regulatory network using evolutionary correlations. PLoS Comput. Biol. 10, e1003860. https://doi.org/10.1371/journal.pcbi.1003860 (2014).
Calderwood, D. A. Talin controls integrin activation. Biochem. Soc. Trans. 32, 434–437. https://doi.org/10.1042/BST0320434 (2004).
Johansson, S., Svineng, G., Wennerberg, K., Armulik, A. & Lohikangas, L. Fibronectin-integrin interactions. Front. Biosci. 2, d126-146. https://doi.org/10.2741/a178 (1997).
Jousimaa, J., Merenmies, J. & Rauvala, H. Neurite outgrowth of neuroblastoma cells induced by proteins covalently coupled to glass coverslips. Eur. J. Cell Biol. 35, 55–61 (1984).
Praekelt, U. et al. New isoform-specific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2. Eur. J. Cell Biol. 91, 180–191. https://doi.org/10.1016/j.ejcb.2011.12.003 (2012).
McCloy, R. A. et al. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. Cell Cycle 13, 1400–1412. https://doi.org/10.4161/cc.28401 (2014).
Park, E. J. et al. Exosomal regulation of lymphocyte homing to the gut. Blood Adv. 3, 1–11. https://doi.org/10.1182/bloodadvances.2018024877 (2019).
Myint, P. K. et al. Irisin supports integrin-mediated cell adhesion of lymphocytes. Biochem. Biophys. Rep. 26, 100977. https://doi.org/10.1016/j.bbrep.2021.100977 (2021).
Weetall, M. et al. A homogeneous fluorometric assay for measuring cell adhesion to immobilized ligand using V-well microtiter plates. Anal. Biochem. 293, 277–287 (2001).
Kawamoto, E., Park, E. J. & Shimaoka, M. Methods to study integrin functions on exosomes. Methods Mol. Biol. 2217, 265–281. https://doi.org/10.1007/978-1-0716-0962-0_15 (2021).
Rodriguez-Fernandez, J. L. et al. The interaction of activated integrin lymphocyte function-associated antigen 1 with ligand intercellular adhesion molecule 1 induces activation and redistribution of focal adhesion kinase and proline-rich tyrosine kinase 2 in T lymphocytes. Mol. Biol. Cell 10, 1891–1907 (1999).
Machado-Pineda, Y. et al. CD9 controls integrin alpha5beta1-mediated cell adhesion by modulating its association with the metalloproteinase ADAM17. Front. Immunol. 9, 2474. https://doi.org/10.3389/fimmu.2018.02474 (2018).
Acknowledgements
We acknowledge Daliya Banerjee (Harvard Medical School) for her technical support and discussion.
Funding
This work was supported by the JSPS KAKENHI; Grants 18H02622, 19K07479, 19K09392, and 19KK0196.
Author information
Authors and Affiliations
Contributions
G.O. mainly performed the experiments; E.J.P., M.G.A., E.K. and A.G. contributed to some of the experiments; E.J.P. and M.S. designed the study and carried out the data interpretation; G.O., E.J.P., and M.S. wrote the manuscript. All authors read and approved the final version.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Obeng, G., Park, E.J., Appiah, M.G. et al. miRNA-200c-3p targets talin-1 to regulate integrin-mediated cell adhesion. Sci Rep 11, 21597 (2021). https://doi.org/10.1038/s41598-021-01143-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-01143-3
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.